| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arteriovenous Shunt, Surgical | 10 | 2023 | 93 | 4.280 |
Why?
|
| Neointima | 15 | 2024 | 47 | 4.260 |
Why?
|
| Myocytes, Smooth Muscle | 12 | 2022 | 190 | 3.470 |
Why?
|
| Muscle, Smooth, Vascular | 15 | 2020 | 237 | 3.080 |
Why?
|
| Arteriovenous Fistula | 9 | 2024 | 54 | 2.740 |
Why?
|
| Renal Insufficiency, Chronic | 10 | 2023 | 803 | 2.480 |
Why?
|
| Endothelial Cells | 8 | 2022 | 530 | 2.230 |
Why?
|
| Ureteral Obstruction | 5 | 2023 | 105 | 1.620 |
Why?
|
| Tunica Intima | 5 | 2017 | 57 | 1.390 |
Why?
|
| Cell Proliferation | 8 | 2020 | 2512 | 1.360 |
Why?
|
| Myofibroblasts | 4 | 2020 | 68 | 1.300 |
Why?
|
| Carotid Artery, Common | 5 | 2020 | 66 | 1.250 |
Why?
|
| Immediate-Early Proteins | 4 | 2016 | 59 | 1.230 |
Why?
|
| Receptors, Notch | 3 | 2019 | 213 | 1.020 |
Why?
|
| Receptor, IGF Type 1 | 6 | 2021 | 95 | 0.960 |
Why?
|
| Glutathione Transferase | 3 | 2017 | 142 | 0.950 |
Why?
|
| S100 Proteins | 3 | 2015 | 47 | 0.940 |
Why?
|
| Integrin beta3 | 5 | 2020 | 29 | 0.930 |
Why?
|
| Venae Cavae | 2 | 2015 | 11 | 0.900 |
Why?
|
| Mice, Knockout | 21 | 2021 | 3873 | 0.900 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2015 | 87 | 0.890 |
Why?
|
| Macrophages | 11 | 2020 | 693 | 0.880 |
Why?
|
| Cells, Cultured | 19 | 2020 | 3062 | 0.860 |
Why?
|
| Mice | 37 | 2023 | 18572 | 0.820 |
Why?
|
| S100 Calcium-Binding Protein A4 | 7 | 2023 | 22 | 0.820 |
Why?
|
| Animals | 51 | 2024 | 34996 | 0.820 |
Why?
|
| Kidney | 6 | 2023 | 1331 | 0.800 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2022 | 35 | 0.730 |
Why?
|
| Re-Epithelialization | 1 | 2020 | 13 | 0.680 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 32 | 0.680 |
Why?
|
| Jagged-1 Protein | 1 | 2020 | 54 | 0.670 |
Why?
|
| Hyperplasia | 5 | 2024 | 196 | 0.670 |
Why?
|
| Signal Transduction | 13 | 2021 | 4725 | 0.650 |
Why?
|
| Aldehydes | 2 | 2017 | 31 | 0.650 |
Why?
|
| Fibrosis | 12 | 2023 | 428 | 0.640 |
Why?
|
| Cell Communication | 1 | 2020 | 187 | 0.630 |
Why?
|
| Mice, Inbred C57BL | 18 | 2020 | 4767 | 0.600 |
Why?
|
| Cell Movement | 4 | 2020 | 891 | 0.600 |
Why?
|
| Smad3 Protein | 2 | 2016 | 58 | 0.580 |
Why?
|
| Angiotensin II | 9 | 2012 | 159 | 0.570 |
Why?
|
| Kidney Diseases | 1 | 2023 | 488 | 0.570 |
Why?
|
| Receptor, Notch1 | 2 | 2015 | 78 | 0.560 |
Why?
|
| Lipoproteins, LDL | 2 | 2007 | 137 | 0.510 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2016 | 31 | 0.490 |
Why?
|
| Smad2 Protein | 1 | 2016 | 54 | 0.490 |
Why?
|
| Down-Regulation | 4 | 2022 | 679 | 0.480 |
Why?
|
| Veins | 5 | 2017 | 101 | 0.470 |
Why?
|
| Fibroblasts | 6 | 2020 | 879 | 0.470 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 623 | 0.460 |
Why?
|
| Regeneration | 2 | 2015 | 226 | 0.460 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 90 | 0.460 |
Why?
|
| Phosphoproteins | 1 | 2017 | 443 | 0.460 |
Why?
|
| Blood Platelets | 2 | 2015 | 325 | 0.450 |
Why?
|
| rho-Associated Kinases | 1 | 2015 | 51 | 0.440 |
Why?
|
| Renal Dialysis | 2 | 2019 | 889 | 0.440 |
Why?
|
| Transfection | 6 | 2018 | 999 | 0.430 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2018 | 241 | 0.430 |
Why?
|
| Bismuth | 2 | 2024 | 83 | 0.430 |
Why?
|
| Endothelium | 1 | 2013 | 67 | 0.400 |
Why?
|
| Kidney Tubules | 1 | 2012 | 75 | 0.380 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 3 | 2019 | 14 | 0.380 |
Why?
|
| Bone Marrow Cells | 3 | 2016 | 263 | 0.370 |
Why?
|
| Coculture Techniques | 3 | 2020 | 239 | 0.360 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 490 | 0.360 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2018 | 134 | 0.360 |
Why?
|
| Vascular Grafting | 1 | 2011 | 49 | 0.360 |
Why?
|
| Male | 32 | 2024 | 65072 | 0.350 |
Why?
|
| Vena Cava, Inferior | 1 | 2011 | 104 | 0.340 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 4695 | 0.340 |
Why?
|
| Coronary Artery Bypass | 1 | 2014 | 537 | 0.330 |
Why?
|
| Cell Differentiation | 5 | 2020 | 1975 | 0.330 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2007 | 71 | 0.330 |
Why?
|
| Apoptosis | 2 | 2007 | 1904 | 0.330 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2024 | 1227 | 0.330 |
Why?
|
| Phosphorylation | 7 | 2017 | 1615 | 0.320 |
Why?
|
| Stress, Mechanical | 4 | 2010 | 174 | 0.290 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2007 | 17 | 0.280 |
Why?
|
| Polyesters | 2 | 2024 | 41 | 0.270 |
Why?
|
| TRPV Cation Channels | 2 | 2018 | 46 | 0.270 |
Why?
|
| Up-Regulation | 3 | 2018 | 879 | 0.270 |
Why?
|
| Cadherins | 3 | 2020 | 180 | 0.270 |
Why?
|
| Models, Animal | 4 | 2015 | 471 | 0.260 |
Why?
|
| Genetic Therapy | 1 | 2011 | 720 | 0.260 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 786 | 0.260 |
Why?
|
| Myocardium | 4 | 2012 | 908 | 0.260 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 2453 | 0.260 |
Why?
|
| Vascular Patency | 2 | 2019 | 187 | 0.250 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 1723 | 0.250 |
Why?
|
| Metal Nanoparticles | 2 | 2024 | 57 | 0.250 |
Why?
|
| RNA, Messenger | 6 | 2017 | 2687 | 0.250 |
Why?
|
| Calcium-Binding Proteins | 3 | 2018 | 333 | 0.230 |
Why?
|
| Vascular Remodeling | 2 | 2022 | 54 | 0.230 |
Why?
|
| Rosuvastatin Calcium | 1 | 2024 | 43 | 0.220 |
Why?
|
| Hypercholesterolemia | 1 | 2007 | 232 | 0.220 |
Why?
|
| DNA Transposable Elements | 2 | 2017 | 187 | 0.210 |
Why?
|
| Jugular Veins | 2 | 2015 | 76 | 0.210 |
Why?
|
| RNA Interference | 3 | 2018 | 516 | 0.210 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2024 | 87 | 0.210 |
Why?
|
| CARD Signaling Adaptor Proteins | 2 | 2015 | 42 | 0.200 |
Why?
|
| Stem Cells | 2 | 2016 | 732 | 0.200 |
Why?
|
| Blotting, Western | 4 | 2016 | 1085 | 0.200 |
Why?
|
| Cell Polarity | 3 | 2012 | 125 | 0.200 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3140 | 0.190 |
Why?
|
| Rats | 8 | 2024 | 3620 | 0.190 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 774 | 0.190 |
Why?
|
| Sirolimus | 1 | 2024 | 241 | 0.190 |
Why?
|
| NF-kappa B | 6 | 2015 | 454 | 0.180 |
Why?
|
| Bone Marrow Transplantation | 3 | 2015 | 618 | 0.180 |
Why?
|
| Interleukin-1beta | 2 | 2020 | 163 | 0.180 |
Why?
|
| Snail Family Transcription Factors | 2 | 2012 | 26 | 0.180 |
Why?
|
| Osteocalcin | 1 | 2021 | 46 | 0.180 |
Why?
|
| Selenoprotein P | 1 | 2021 | 3 | 0.170 |
Why?
|
| Cytokines | 3 | 2023 | 1368 | 0.170 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2021 | 37 | 0.170 |
Why?
|
| Selenium | 1 | 2021 | 17 | 0.170 |
Why?
|
| Bone Marrow | 1 | 2023 | 332 | 0.170 |
Why?
|
| Inflammation | 5 | 2020 | 1526 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2016 | 503 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2017 | 714 | 0.170 |
Why?
|
| Gene Expression | 4 | 2018 | 1564 | 0.170 |
Why?
|
| Sperm Motility | 1 | 2021 | 113 | 0.160 |
Why?
|
| Molecular Weight | 1 | 2020 | 310 | 0.160 |
Why?
|
| Inflammation Mediators | 2 | 2011 | 242 | 0.160 |
Why?
|
| Extracellular Matrix | 2 | 2020 | 238 | 0.160 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 691 | 0.160 |
Why?
|
| Atherosclerosis | 1 | 2007 | 1000 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 3 | 2017 | 309 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2021 | 238 | 0.150 |
Why?
|
| Aquaporin 1 | 1 | 2019 | 8 | 0.150 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 21 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1997 | 0.150 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 108 | 0.150 |
Why?
|
| Testis | 1 | 2021 | 423 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 1556 | 0.140 |
Why?
|
| Plasmids | 2 | 2018 | 459 | 0.140 |
Why?
|
| Gastrointestinal Motility | 1 | 2018 | 55 | 0.140 |
Why?
|
| Kidney Pelvis | 1 | 2018 | 46 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2010 | 618 | 0.140 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2017 | 4 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2015 | 138 | 0.140 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2017 | 36 | 0.140 |
Why?
|
| Dermis | 1 | 2017 | 27 | 0.140 |
Why?
|
| Pruritus | 1 | 2017 | 42 | 0.140 |
Why?
|
| Keratinocytes | 1 | 2017 | 63 | 0.130 |
Why?
|
| Schistosomiasis japonica | 2 | 2007 | 6 | 0.130 |
Why?
|
| Transcription Factors | 3 | 2012 | 2494 | 0.130 |
Why?
|
| Transcription Factor RelA | 3 | 2005 | 54 | 0.130 |
Why?
|
| Hypoxia | 1 | 2019 | 261 | 0.130 |
Why?
|
| Glucose | 1 | 2021 | 911 | 0.130 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 2446 | 0.130 |
Why?
|
| Vaccines, DNA | 2 | 2007 | 49 | 0.130 |
Why?
|
| Arteries | 1 | 2017 | 221 | 0.130 |
Why?
|
| Helminth Proteins | 2 | 2007 | 103 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 2 | 2021 | 396 | 0.120 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2018 | 101 | 0.120 |
Why?
|
| Actins | 2 | 2018 | 338 | 0.120 |
Why?
|
| Gene Deletion | 2 | 2017 | 795 | 0.120 |
Why?
|
| Colon | 1 | 2018 | 371 | 0.120 |
Why?
|
| Cardiac Myosins | 1 | 2015 | 11 | 0.120 |
Why?
|
| Myosin Light Chains | 1 | 2015 | 16 | 0.120 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 350 | 0.120 |
Why?
|
| Umbilical Veins | 1 | 2015 | 70 | 0.110 |
Why?
|
| Humans | 15 | 2024 | 132373 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 590 | 0.110 |
Why?
|
| MAP Kinase Kinase 1 | 3 | 2010 | 44 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2015 | 327 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 235 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 1294 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2021 | 503 | 0.110 |
Why?
|
| Anastomosis, Surgical | 1 | 2014 | 167 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 464 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 3 | 2012 | 475 | 0.100 |
Why?
|
| Diet | 1 | 2021 | 1174 | 0.100 |
Why?
|
| Absorbable Implants | 2 | 2023 | 26 | 0.100 |
Why?
|
| Monocytes | 2 | 2016 | 345 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 686 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 449 | 0.100 |
Why?
|
| Intercellular Junctions | 1 | 2012 | 25 | 0.100 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2012 | 6 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2012 | 8 | 0.100 |
Why?
|
| Lipid Peroxidation | 1 | 2012 | 93 | 0.090 |
Why?
|
| Phagosomes | 1 | 2012 | 38 | 0.090 |
Why?
|
| Cathepsins | 1 | 2012 | 25 | 0.090 |
Why?
|
| DNA | 1 | 2018 | 1484 | 0.090 |
Why?
|
| Macrophage Activation | 1 | 2012 | 65 | 0.090 |
Why?
|
| Autophagy | 2 | 2012 | 428 | 0.090 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2011 | 4 | 0.090 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2011 | 9 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2011 | 10 | 0.090 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2011 | 26 | 0.090 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 36 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 2 | 2010 | 140 | 0.090 |
Why?
|
| Aneurysm | 1 | 2012 | 81 | 0.090 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 68 | 0.090 |
Why?
|
| Antigens, CD | 2 | 2018 | 437 | 0.090 |
Why?
|
| Nanoparticles | 2 | 2024 | 288 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2011 | 117 | 0.090 |
Why?
|
| Genes, Reporter | 3 | 2021 | 365 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 761 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 110 | 0.080 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 37 | 0.080 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 68 | 0.080 |
Why?
|
| Reactive Oxygen Species | 3 | 2012 | 515 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 60 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 61 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 62 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2012 | 438 | 0.080 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 119 | 0.080 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2009 | 38 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 246 | 0.080 |
Why?
|
| Cardiomegaly | 1 | 2010 | 125 | 0.080 |
Why?
|
| Protein Transport | 1 | 2010 | 370 | 0.080 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2009 | 74 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 343 | 0.070 |
Why?
|
| Antigens, Helminth | 2 | 2007 | 188 | 0.070 |
Why?
|
| Aged | 3 | 2018 | 21386 | 0.070 |
Why?
|
| Schistosoma japonicum | 1 | 2007 | 10 | 0.070 |
Why?
|
| Phenotype | 1 | 2017 | 4545 | 0.070 |
Why?
|
| Integrin beta1 | 1 | 2007 | 56 | 0.070 |
Why?
|
| LIM Domain Proteins | 1 | 2007 | 64 | 0.070 |
Why?
|
| Hydrodynamics | 2 | 2018 | 28 | 0.070 |
Why?
|
| Ionophores | 1 | 2007 | 11 | 0.070 |
Why?
|
| Calcimycin | 1 | 2007 | 21 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1046 | 0.070 |
Why?
|
| AC133 Antigen | 1 | 2007 | 37 | 0.070 |
Why?
|
| Probability | 1 | 2007 | 323 | 0.060 |
Why?
|
| Base Sequence | 2 | 2009 | 2904 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2007 | 171 | 0.060 |
Why?
|
| Sheep | 1 | 2007 | 229 | 0.060 |
Why?
|
| Middle Aged | 3 | 2018 | 28895 | 0.060 |
Why?
|
| Carotid Arteries | 1 | 2007 | 136 | 0.060 |
Why?
|
| Vasodilation | 1 | 2007 | 180 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2007 | 174 | 0.060 |
Why?
|
| Mitochondria | 2 | 2012 | 752 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 3780 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2005 | 50 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 608 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2018 | 1598 | 0.060 |
Why?
|
| I-kappa B Kinase | 1 | 2005 | 58 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2011 | 1373 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2005 | 36 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 1042 | 0.060 |
Why?
|
| Cell Survival | 1 | 2007 | 869 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2007 | 825 | 0.060 |
Why?
|
| Vasculitis | 1 | 2005 | 50 | 0.060 |
Why?
|
| Drug Liberation | 1 | 2024 | 36 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2007 | 377 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 1292 | 0.050 |
Why?
|
| Chaperonins | 1 | 2004 | 15 | 0.050 |
Why?
|
| Aorta | 1 | 2007 | 554 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1881 | 0.050 |
Why?
|
| Peptides | 1 | 2007 | 847 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2004 | 112 | 0.050 |
Why?
|
| Gold | 1 | 2023 | 57 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2003 | 92 | 0.050 |
Why?
|
| Tissue Scaffolds | 1 | 2023 | 79 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2004 | 322 | 0.050 |
Why?
|
| Genetic Vectors | 3 | 2017 | 927 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 2145 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 198 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2003 | 303 | 0.050 |
Why?
|
| Leukocyte Common Antigens | 2 | 2012 | 91 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 78 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2021 | 97 | 0.040 |
Why?
|
| Selenoproteins | 1 | 2021 | 15 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 223 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 1426 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2021 | 161 | 0.040 |
Why?
|
| Time Factors | 1 | 2010 | 6457 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 147 | 0.040 |
Why?
|
| Collagen | 2 | 2012 | 309 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2004 | 413 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 303 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 796 | 0.040 |
Why?
|
| Spermatozoa | 1 | 2021 | 244 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2019 | 113 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 27 | 0.040 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2018 | 8 | 0.040 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 101 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 930 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2018 | 70 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2003 | 816 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2018 | 154 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2003 | 1049 | 0.030 |
Why?
|
| Injections | 1 | 2018 | 153 | 0.030 |
Why?
|
| Transgenes | 1 | 2018 | 336 | 0.030 |
Why?
|
| Insulin | 1 | 2021 | 1211 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2017 | 109 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 413 | 0.030 |
Why?
|
| Cell Separation | 1 | 2016 | 227 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 2169 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2007 | 732 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2018 | 491 | 0.030 |
Why?
|
| Necrosis | 1 | 2015 | 210 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 686 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 806 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 1829 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 1541 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2017 | 1229 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 672 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2012 | 21 | 0.020 |
Why?
|
| Myogenin | 1 | 2011 | 10 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2011 | 24 | 0.020 |
Why?
|
| Hydralazine | 1 | 2011 | 8 | 0.020 |
Why?
|
| Muscle Development | 1 | 2011 | 75 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 2011 | 31 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 637 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 431 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 232 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 544 | 0.020 |
Why?
|
| Elasticity | 1 | 2009 | 93 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 667 | 0.020 |
Why?
|
| Escherichia coli | 2 | 2006 | 995 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2010 | 175 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7112 | 0.020 |
Why?
|
| Immunization | 1 | 2007 | 312 | 0.020 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2005 | 10 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 2005 | 27 | 0.020 |
Why?
|
| Luciferases | 1 | 2005 | 129 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2005 | 50 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 68 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 123 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 197 | 0.010 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 236 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 1052 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 142 | 0.010 |
Why?
|
| ras Proteins | 1 | 2005 | 146 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2004 | 32 | 0.010 |
Why?
|
| Proteolipids | 1 | 2003 | 8 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2003 | 108 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2003 | 42 | 0.010 |
Why?
|
| K562 Cells | 1 | 2003 | 97 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 1255 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 813 | 0.010 |
Why?
|
| Biological Transport | 1 | 2003 | 358 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2003 | 222 | 0.010 |
Why?
|
| Liposomes | 1 | 2003 | 203 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 198 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 275 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1735 | 0.010 |
Why?
|
| Hypertension | 1 | 2010 | 1343 | 0.010 |
Why?
|
| Female | 2 | 2018 | 70809 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 474 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 540 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 803 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2003 | 332 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 1807 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 31624 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 3698 | 0.010 |
Why?
|